Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 5751–5800 of 75391
Scott W. Kingsmore, the Company’s current Senior Executive Vice President, Chief Financial Officer and Treasurer, will be departing the Company effective as of December 31, 2024.
On November 3, 2024, Mojdeh Poul informed the board of directors (the “Board”) of Stanley Black & Decker, Inc. (the “Company”) of her decision not to stand for re-election as a director of the Company at the Company’s 2025 annual meeting of shareholders (the “2025 Annual Meeting”).
Tom Einar Jensen, the Company’s Chief Executive Officer (“ CEO ”), would be resigning from his position as CEO and as a director of the Company, effective immediately
On November 4, 2024, Seah Lim, M.D., Ph.D., resigned as a director of Emmaus Life Sciences, Inc. (“we,” “us,” “our,” “Emmaus” or the “company”) for personal reasons and expressed his best wishes to the company.
Daniel Levangie, tendered his resignation from the Company's Board of Directors and all committees effective on October 31, 2024.
As previously disclosed, on September 18, 2024, Shrisha Radhakrishna resigned from his positions as Chief Technology Officer and Chief Product Officer of LegalZoom to pursue other opportunities, with such resignation originally to be effective November 15, 2024. Mr. Radhakrishna’s resignation is now effective November 4, 2024.
(a) David M. Shaffer has advised EnerSys of his intention to retire as Chief Executive Officer of EnerSys and member of its Board of Directors effective May 22, 2025,
On November 5, 2024, Jacques N. Gordon tendered his resignation from his position as a member of the Board of Directors (the "Board") of JLL Income Property Trust, Inc. (the "Company"), effective as of November 5, 2024.
Mr. Hallé will succeed Todd Dissinger, who, as previously announced, will retire on December 31, 2024.
On November 6, 2024, the Company announced that Mr. James Brady, Executive Vice President and Chief Operating Officer will be exiting the Company effective November 29, 2024.
W. Andrew Adams notified National Health Investors, Inc. (the “Company”) of his decision to retire from his position as Chairperson and a member of the Board of Directors (the “Board”) effective December 31, 2024.
On October 30, 2024, Ulf Wiinberg resigned as a director at Agenus Inc. (the “Company”), effective as of 5:00 p.m. Eastern Time on November 5, 2024.
On October 30, 2024, Wetteny Joseph, a member of the Board of Directors (the “Board”) of Ashland Inc. (the “Company”), notified the Company of his decision to not stand for reelection to the Board at the Company’s 2025 Annual Meeting of Stockholders (the “Annual Meeting”).
On October 31, 2024, in connection with the previously announced retirement of Frank Pelzer, Executive Vice President and Chief Financial Officer of F5, Inc. (the “Company”), the Company and Mr. Pelzer entered into a Transition Agreement (the “Transition Agreement”).
Thomas Fahnemann resigned from his position as the President and Chief Executive Officer
Ramesh Shettigar resigned from his position as the Senior Vice President, Chief Financial Officer & Treasurer
David C. Elder resigned from his position as Vice President, Strategic Initiatives, Business Optimization & Chief Accounting Officer
Boris Illetschko resigned from his position as the Senior Vice President, Chief Operating Officer
On October 31, 2024, Greg Ethridge, the Chief Financial Officer of Canoo who previously served as the CFO of Canoo’s SPAC sponsor Hennessey Capital before transitioning to the Company’s Board as the SPAC’s representative and Hector Ruiz, General Counsel and Corporate Secretary of Canoo, notified Canoo of their resignations.
On October 31, 2024, Greg Ethridge, the Chief Financial Officer of Canoo who previously served as the CFO of Canoo’s SPAC sponsor Hennessey Capital before transitioning to the Company’s Board as the SPAC’s representative and Hector Ruiz, General Counsel and Corporate Secretary of Canoo, notified Canoo of their resignations.
Mr. Yee will fill an upcoming vacancy resulting from the December 11, 2024 retirement of long-time Director Geoffrey L. Stack.
the vacancy being created by William J. Fehrman’s resignation
Karin Rådström and Kristin Slanina resigned as members of Ouster, Inc.’s (the “Company”) Board of Directors (the “Board”), effective November 4, 2024.
Karin Rådström and Kristin Slanina resigned as members of Ouster, Inc.’s (the “Company”) Board of Directors (the “Board”), effective November 4, 2024.
On November 1, 2024, Dr. Hideki Garren provided Coya Therapeutics, Inc. (the “Company”) with notice of his resignation from the Board of Directors, effective immediately.
he would serve until November 15, 2024 as the Company’s Chief Financial Officer
Sunny Bhandarkar, the CEO and a director of Mobile Global Esports, Inc. (the “Company”) resigned as CEO and a director for personal reasons.
Raymond Chang resigned as a member of the Board of Directors (the “Board”) of the Company and any subsidiaries and as President and Chief Executive Officer of the Company
I-Tseng Jenny Chan resigned as a member of the Board.
Nandita V. Berry and David F. Taylor will step down from the Board effective immediately.
Nandita V. Berry and David F. Taylor will step down from the Board effective immediately.
On November 4, 2024, Mr. Wood notified the Board that he was retiring, effective immediately for personal reasons
On November 1, 2024, Mr. Mesrobian resigned his position as Vice President of Sales and Marketing.
On October 30, 2024, the Company accepted the resignations of Nicholas Fazio from his positions as Director and Chief Executive Officer of the Company
On October 30, 2024, the Company accepted the resignations of Nicholas Fazio from his positions as Director and Chief Executive Officer of the Company
As result of the appointment of Mr. David Finn, the Company hereby confirms the retirement of Joseph Perillo as the Chief Financial Officer and Executive Vice President of the Company and the Bank, effective on October 30, 2024.
On November 1, 2024, Brian Krzanich resigned from the Board of Directors (the “Board”) of SES AI Corporation (“SES AI”) effective immediately.
In connection with the appointment, on November 1, 2024, Dr. Yeu resigned as a member of the Company's board of directors (the "Board") and from the committees of the Board on which she served, each effective as of the Effective Date.
On October 30, 2024, Douglas Elliman Inc. (the “Company”) and James D. Ballard, the Company’s Senior Vice President – Enterprise Efficiency and Chief Technology Officer, mutually agreed to terminate Mr. Ballard’s employment, effective immediately.
On November 1, 2024, Timothy G. Henry, President and Chief Executive Officer of Franklin Financial Services Corporation and President and Chief Executive Officer of its wholly-owned subsidiary, Farmers and Merchants Trust Company of Chambersburg, announced his retirement effective April 29, 2025.
the position of Chief Product Officer, held by Hillary Ashton, a Named Executive Officer of the Company, will be eliminated effective as of December 31, 2024 (the "CPO Transition").
As interim Chief Executive Officer, Mr. Creedon succeeds Richard W. Dreiling, whose separation from the Company and resignation as a director was effective November 3, 2024.
On November 1, 2024, Troy Reisner notified Phunware, Inc. (the “Company”) that he intends to step down as Chief Financial Officer of the Company on or after November 15, 2024 and prior to November 30, 2024.
On October 31, 2024, Aaron Davis, a member of the Board of Directors (the “ Board ”) of iTeos Therapeutics, Inc. (the “ Company ”), resigned from the Board, effective November 1, 2024.
Rick Rickertsen announced that he has determined to resign from his position as a director of the Company, effective November 4, 2024.
Effective November 4, 2024, Bryan Yamasawa will cease serving as the Company’s Chief Accounting Officer but will remain an at-will employee to provide such transition and advisory services as requested by the Company through November 15, 2024
previously reported Timothy S. Duncan departed his role as President and Chief Executive Officer of the Company
Mr. Duncan also resigned as a member of the Board.
At the closing of the Merger, Robert S. Murley, Cindy J. Miller, Victoria L. Dolan, Naren K. Gursahaney, James L. Welch, J. Joel Hackney, Jr., Stephen C. Hooley, Brian P. Anderson, Lynn D. Bleil and Thomas F. Chen, members of the board of directors of Stericycle, ceased to be directors of Stericycle
At the closing of the Merger, Cindy J. Miller, Janet H. Zelenka, S. Cory White, Daniel V. Ginnetti, Kurt M. Rogers and Richard J. Hoffman, officers of Stericycle, ceased to be officers of Stericycle
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.